Sphera Funds Management Ltd. Athira Pharma, Inc. Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$16.9 - $29.77 $910,909 - $1.6 Million
-53,900 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$16.48 - $34.3 $957,488 - $1.99 Million
-58,100 Reduced 51.88%
53,900 $1.85 Million
Q3 2020

Nov 12, 2020
BUY
$16.02 - $18.46 $1.79 Million - $2.07 Million
112,000 New
112,000 $2.07 Million

Others Institutions Holding ATHA

# of Institutions
66
Shares Held
16.9M
Call Options Held
112K
Put Options Held
68K
View Full List

About Athira Pharma, Inc.

ATHA Quotes by TradingView
  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $23.4M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email